Stem cell use in critical limb ischemia

Journal of Cardiovascular Surgery

Volumn 48, Issue 1, 2007, Pages 39-44

  Kolvenbach, R ^a   Kreissig, C ^b   Ludwig, E ^b   Cagiannos, C ^b  

^a Augusta Hospital   (Germany)

^b Department of Cell Therapy Red Cross ^*  (Germany)

Author keywords

Ischemia; Limb; Stem cells

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CD133 ANTIGEN; CD34 ANTIGEN; DNA; ESTROGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VASCULOTROPIN; VIRUS VECTOR;

ARTERY DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BUERGER DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; LIMB ISCHEMIA; MESENCHYMAL STEM CELL; PATIENT SAFETY; REVIEW; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION;

HUMANS; ISCHEMIA; LEG; SEVERITY OF ILLNESS INDEX; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 33947239429     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Cannon RO. Cardiovascular potential of bone marrow derived stem and progenitor cells. Cytotherapy 2004;6:602-7.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
3. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic revascularisation. Proc Natl Acad Sci U S A 2000;97:3422-7.
4. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M et al. Expression of VGFER-2 and CD133 by circulating CD34-positive cells identifies a population of functional endothelial precursors. Blood 2000;95:952-8.
5. Higashi Y, Kimura M, Hara K, Noma K, Jitsuiki D, Nakagawa K et al. Autologous bone marrow nuclear cell implantation improves endothelium-dependent vasodilatation in patients with limb ischemia. Circulation 2004;109:1215-8.
6. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M et al. In vitro differentiation of endothelial cells from AC133-positive cells. Blood 2000;95:3106-12.
7. Lin Y, Weisdorf DJ, Solovey, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:1-7.
8. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002;106:3009-17.
9. Schächinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004;44:1690-9.
10. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-8.
11. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751-6.
12. Schächinger V, Tonn T, Dimmeler S, Zeiher AM. Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat Clin Pract Cardiovasc Med 2006;3:Suppl 1:S23-8.
13. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005;115:572-83.
14. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Holschermann H et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-21.
15. Assumus B, Honold J, Schächinger V, Britten M, Fischer-Rasokat U, Lehmann R et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-32.
16. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-209.
17. Esato K, Hamano K, Li TS, Furutani A, Seyama A, Takenaka H et al. Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant 2002;11:747-52.
18. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360:427-35.
19. Kim EJ, Li RK, Weisel RD, Mickle DA, Jia ZQ, Tomita S et al. Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg 2001;122:963-71.
20. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004;109:1543-9.
21. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8.
22. Durdu S, Akar AR, Arat M, Sancak T, Eren NT, Ozyurda U. Autologous bone marrow mononuclear cell implantation for patients with Rutherford grade II - III thromboangiitis obliterans. J Vasc Surg 2006;44:732-9.
23. Ishida A, Ohya Y, Sakuda H, Ohshiro K, Higashiuesato Y, Nakaema M et al. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia. Circ J 2005;69:1260-5.
24. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 2003;100:12313-8.
25. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003;107:1164-9.
26. Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol 2001;17:387-403.
27. Hristov M, Erl W, Weber PC. Endothelial progenitor cells. Mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003;23:1185-9.
28. Yau TM, Fung K, Weisel RD, Fujii T, Mickle DA, Li RK. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 2001; 104: 1218-22.
29. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
30. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001;103:634-7.
31. Fernandez-Aviles F, San Roman JA, Garcia-Frade J, Fernandez ME, Penarrubia MJ, de la Fuente L et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004;95:742-8.
32. Koller M, Bradley M, Palsson B. Growth factor consumption and production in perfusion cultures of human bone marrow correlate with specific cell production. Exp Hematol 1995;23:1275-83.
33. Koller M, Emerson S, Palsson B. Large scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 1993;82:378-84.
34. Koller M, Manchel I, Newsom B, Palsson M, Palsson B. Bioreactor expansion of human bone marrow: comparison of unprocessed, density-separated and CD34-enriched cells. J Neurosurg Spine 1995;4:159-69.
35. Lane J, Yasko ATE, Cole B, Waller SBM, Turek T, Gross J. Bone marrow and recombinant human bone morphogenetic protein-2 in osseous repair. Clin Orthop Rel Res 1999;(361):216-27.
36. Martin T. Paracrine regulation of osteoclast formation and activity: milestones in discovery. J Musculoskel Neuronal Interactions 2004;4:243-53.
37. Muschler G, Nitto H, Matsukura Y, Boehm C, Valdevit A, Kambic H et al. Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin Orthop Relat Res 2003;(407):102-18.
38. Rosenzweig A. Cardiac cell therapy - mixed results from mixed cells. N Engl J Med 2006;355:1274-7.
39. Bartunek J, Dimmler S, Drexler H, Fernandez-Aviles F, Fernandez-Aviles F, Galinanes M, Janssens S et al. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J 2006;27:1338-40.